Profil de l'entreprise

Vous venez de lire:

NeuroSigma Receives Health Canada Approval for Its Monarch eTNS System for the Treatment of Drug-Resistant Epilepsy and Major Depressive Disorder

Nouvelles fournies par

NeuroSigma, Inc.

May 02, 2013, 06:06 ET